Suppr超能文献

重新定义姑息治疗相关诊断组 (DRGs)——在两个德国中心的横断面研究。

Redefining diagnosis-related groups (DRGs) for palliative care - a cross-sectional study in two German centres.

机构信息

Helmholtz Zentrum Munich, German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, Munich, Germany.

Ludwig-Maximilians-Universitaet Munich, Munich School of Management, Institute of Health Economics and Health Care Management & Munich Centre of Health Sciences, Munich, Germany.

出版信息

BMC Palliat Care. 2018 Apr 5;17(1):58. doi: 10.1186/s12904-018-0307-3.

Abstract

BACKGROUND

Hospital costs and cost drivers in palliative care are poorly analysed. It remains unknown whether current German Diagnosis-Related Groups, mainly relying on main diagnosis or procedure, reproduce costs adequately. The aim of this study was therefore to analyse costs and reimbursement for inpatient palliative care and to identify relevant cost drivers.

METHODS

Two-center, standardised micro-costing approach with patient-level cost calculations and analysis of the reimbursement situation for patients receiving palliative care at two German hospitals (7/2012-12/2013). Data were analysed for the total group receiving hospital care covering, but not exclusively, palliative care (group A) and the subgroup receiving palliative care only (group B). Patient and care characteristics predictive of inpatient costs of palliative care were derived by generalised linear models and investigated by classification and regression tree analysis.

RESULTS

Between 7/2012 and 12/2013, 2151 patients received care in the two hospitals including, but not exclusively, on the PCUs (group A). In 2013, 784 patients received care on the two PCUs only (group B). Mean total costs per case were € 7392 (SD 7897) (group A) and € 5763 (SD 3664) (group B), mean total reimbursement per case € 5155 (SD 6347) (group A) and € 4278 (SD 2194) (group B). For group A/B on the ward, 58%/67% of the overall costs and 48%/53%, 65%/82% and 64%/72% of costs for nursing, physicians and infrastructure were reimbursed, respectively. Main diagnosis did not significantly influence costs. However, duration of palliative care and total length of stay were (related to the cost calculation method) identified as significant cost drivers.

CONCLUSIONS

Related to the cost calculation method, total length of stay and duration of palliative care were identified as significant cost drivers. In contrast, main diagnosis did not reflect costs. In addition, results show that reimbursement within the German Diagnosis-Related Groups system does not reproduce the costs adequately, but causes a financing gap for inpatient palliative care.

摘要

背景

姑息治疗的医院成本和成本驱动因素分析不足。目前尚不清楚主要依据主要诊断或治疗过程的德国诊断相关组(Diagnosis-Related Groups,DRG)是否能充分再现成本。因此,本研究的目的是分析住院姑息治疗的成本和报销情况,并确定相关的成本驱动因素。

方法

采用双中心、标准化微成本方法,对两家德国医院的姑息治疗患者进行患者层面的成本计算和报销情况分析(2012 年 7 月至 2013 年 12 月)。对接受医院治疗(不仅限于姑息治疗)的总人群(A 组)和仅接受姑息治疗的亚组(B 组)进行了分析。通过广义线性模型得出预测姑息治疗住院费用的患者和护理特征,并通过分类回归树分析进行调查。

结果

2012 年 7 月至 2013 年 12 月,2151 名患者在两家医院接受治疗,包括但不限于姑息治疗单元(A 组)。2013 年,共有 784 名患者仅在两个姑息治疗单元接受治疗(B 组)。每组患者的平均总成本分别为 7392 欧元(SD 7897)(A 组)和 5763 欧元(SD 3664)(B 组),平均总报销额分别为 5155 欧元(SD 6347)(A 组)和 4278 欧元(SD 2194)(B 组)。A 组/ B 组病房的治疗中,58%/67%的总费用和 48%/53%、65%/82%和 64%/72%的护理、医生和基础设施费用得到报销。主要诊断对成本没有显著影响。然而,姑息治疗的持续时间和总住院时间(与成本计算方法有关)被确定为显著的成本驱动因素。

结论

与成本计算方法相关,总住院时间和姑息治疗持续时间被确定为显著的成本驱动因素。相比之下,主要诊断并不能反映成本。此外,结果表明,德国诊断相关组(Diagnosis-Related Groups,DRG)系统内的报销不能充分再现成本,而是导致住院姑息治疗的资金缺口。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验